Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432796
Status:
UNKNOWN
Last Update Posted:
2020-02-19
First Post:
2007-02-07
Brief Title:
PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin
Sponsor:
Lawson Health Research Institute
Organization:
Lawson Health Research Institute
Organization Data
Organization:
Lawson Health Research Institute
Class:
OTHER
Study ID:
R-06-267
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lawson Health Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Michael Kovacs
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Lawson Health Research Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |
| Canadian Institutes of Health Research CIHR | OTHER_GOV |